Iron Mountain Incorporated Prices Debt Offering
PORTSMOUTH, N.H.–(BUSINESS WIRE)–Iron Mountain Incorporated (NYSE: IRM) (the “Company”), a global leader in innovative storage,…
PORTSMOUTH, N.H.–(BUSINESS WIRE)–Iron Mountain Incorporated (NYSE: IRM) (the “Company”), a global leader in innovative storage,…
Tournament Challenge reveals top contact center priorities in 2023 SAN RAMON, Calif.–(BUSINESS WIRE)–Five9, (NASDAQ: FIVN)…
CINCINNATI, May 10, 2023 (GLOBE NEWSWIRE) — Blue Water Biotech, Inc. (“Blue Water” or the…
Marlboro, New Jersey–(Newsfile Corp. – May 10, 2023) – AmpaCash, a fintech company that specializes…
CHARLOTTE, N.C.–(BUSINESS WIRE)–Charlotte-based private equity firm, Broadtree Partners, announced it has successfully acquired Triage Partners,…
NEW YORK–(BUSINESS WIRE)–Morgan Stanley Investment Management (“MSIM”) and Opportunity Finance Network (“OFN”) today announced the…
Former Citigroup executive brings nearly 30 years of alternative asset experience to the private market…
Segra Named Official IT Infrastructure Partner of TRD SALISBURY, N.C.–(BUSINESS WIRE)–Toyota Racing Development (TRD) is…
Monthly information relative to the total number of voting rights and shares composing the…
Monthly information relative to the total number of voting rights and shares composing the…
EDISON, N.J., May 10, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…
EDISON, N.J., May 10, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…
May 10, 2023 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2023…
May 10, 2023 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2023…
VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) — MindBio Therapeutics (CSE:MBIO), through its scientific…
VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) — MindBio Therapeutics (CSE:MBIO), through its scientific…
IRVINE, Calif., May 10, 2023 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”)…
IRVINE, Calif., May 10, 2023 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”)…
Positive results from interim analysis of vafidemstat’s PORTICO Phase IIb trial in Borderline Personality Disorder…
Positive results from interim analysis of vafidemstat’s PORTICO Phase IIb trial in Borderline Personality Disorder…